1-16 of 16
Meirav Kedmi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bisantrene in Combination with Fludarabine and Clofarabine As Salvage Therapy for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)- an Open-Label, Phase II, Study

Ivetta Danylesko, Avichai Shimoni, Abraham Avigdor, Meirav Kedmi, Noga Shem-Tov, Ronit Yerushalmi, Maya Sasson, Dan Dominissini, Borje S. Andersson, Arnon Nagler
Journal: Blood
Blood (2023) 142 (Supplement 1): 4292.
https://doi.org/10.1182/blood-2023-178286
Published: 2023
Journal Articles

Efficacy and Safety of Glofitamab in Patients with R/R DLBCL in Real Life Setting - a Retrospective Study

Ronit Gurion, Dmitri Guz, Meirav Kedmi, Chava Perry, Irit Avivi Mazza, Netanel A. Horowitz, Uri Abadi, Anat Gafter-Gvili, Pia Raanani, Neta Goldschmidt, Boaz Nachmias, Shlomzion Aumann
Journal: Blood
Blood (2023) 142 (Supplement 1): 5170.
https://doi.org/10.1182/blood-2023-186033
Published: 2023
Journal Articles

Pre-Treatment Pulmonary Assessment Have Limited Utility in B-Cell Lymphoma Patients Treated with Autologous Anti-CD19 CAR T-Cell Therapy

Inbal Sdayoor, Roni Shouval, Shalev Fried, Ronit Marcus, Ivetta Danylesko, Ronit Yerushalmi, Noga Shem-Tov, Orit Itzhaki, Elad Jacoby, Meirav Kedmi, Arnon Nagler, Avichai Shimoni, Michael J Segel, Abraham Avigdor
Journal: Blood
Blood (2023) 142 (Supplement 1): 3519.
https://doi.org/10.1182/blood-2023-180115
Published: 2023
Journal Articles

High Response Rates Following Point-of-Care Anti-CD19 CAR T-Cell Therapy in Adults with Relapsed/Refractory Acute B Lymphoblastic Leukemia

Shalev Fried, Ivetta Danylesko, Ronit Marcus, Orit Itzhaki, Ronit Yerushalmi, Noga Shem-Tov, Inbal Sdayoor, Roni Shouval, Elad Jacoby, Meirav Kedmi, Arnon Nagler, Avichai Shimoni, Abraham Avigdor
Journal: Blood
Blood (2023) 142 (Supplement 1): 6875.
https://doi.org/10.1182/blood-2023-178477
Published: 2023
Journal Articles

The Impact of Cardiovascular Vulnerabilities in Non Hodgkin Lymphoma Patients Treated with Chimeric Antigen Receptor T Cell Therapy

Ivan Landego, Jessica R Flynn, Adam Goldman, Sean M. Devlin, Efrat Luttwak, Alejandro Luna De Abia, Magdalena Corona, Meirav Kedmi, Inbal Sdayoor, Shalev Fried, Noga Shem-Tov, Avichai Shimoni, Ivetta Danylesko, Mohammad Hammoud, Ronit Yerushalmi, Arnon Nagler, Ronit Marcus, Ahmed El-Moghraby, Mahin Rehman, Parastoo B. Dahi, Sergio A. Giralt, Richard J. Lin, Maria Lia Palomba, Michael Scordo, Gunjan L. Shah, Miguel-Angel Perales, Syed Mahmood, Abraham Avigdor, Jennifer Liu, Roni Shouval
Journal: Blood
Blood (2023) 142 (Supplement 1): 6908.
https://doi.org/10.1182/blood-2023-187338
Published: 2023
Journal Articles

Nivolumab Maintenance in First Complete Remission of Diffuse Large B-Cell Lymphoma

Meirav Kedmi, Elena Ribakovsky, Ohad Benjamini, Avichai Shimoni, Abraham Avigdor
Journal: Blood
Blood (2022) 140 (Supplement 1): 12071–12072.
https://doi.org/10.1182/blood-2022-158742
Published: 2022
Journal Articles

Inflammatory Biomarker Clusters Are Predictive of Response and Toxicity in Large B-Cell Lymphoma Treated with CD19 CAR-T Cell Therapy

Sandeep Raj, Miguel-Angel Perales, Joshua A Fein, Ana Alarcon Tomas, Connie Lee Batlevi, Magdalena Corona De Lapuerta, Parastoo B Dahi, Ivetta Danylesko, Shalev Fried, Tyler Funnell, Sergio A. Giralt, Elad Jacoby, Meirav Kedmi, Richard J. Lin, Arnon Nagler, Karthik Nath, Allison Parascondola, M.Lia Palomba, Gilles Salles, Michael Scordo, Gunjan L. Shah, Noga Shem-Tov, Avichai Shimoni, John Slingerland, Moneeza Walji, Ronit Yerushalmi, Abraham Avigdor, Marcel R M van den Brink, Roni Shouval
Journal: Blood
Blood (2022) 140 (Supplement 1): 648–650.
https://doi.org/10.1182/blood-2022-162286
Published: 2022
Journal Articles

Progression of Follicular Lymphoma within 24 Months of First Treatment (POD -24) As a Predictor of Overall Survival - a Single Center Retrospective Analysis

Guy Bitansky, Elena Vasilev, MD, Maya Zlotnick, MD, Elena Ribakovsky, MD, Ohad Benjamini, MD, Arnon Nagler, MD MSc, Abraham Avigdor, MD, Meirav Kedmi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1534.
https://doi.org/10.1182/blood-2019-125218
Published: 2019
Journal Articles

Ibrutinib, Bendamustine, Rituximab Combination for Relapsed and Refractory Aggressive B Cell Lymphoma — Interim Analysis of Phase II Clinical Trial

Meirav Kedmi, MD, Elena Ribakovsy, MD, Ohad Benjamini, MD, Ginette Schiby, MD, Iris Barshack, MD, Stephen P Raskin, MD, Yael Eshet, MD, Ramit Mehr, PhD, Guy Bitansky, Arnon Nagler, MD, Abraham Avigdor, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4186.
https://doi.org/10.1182/blood-2018-99-111658
Published: 2018
Journal Articles

Evaluation of the Risk of Hepatitis B Reactivation Among Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

Ohad Benjamini, MD, Maya Zlotnick, MD, Elena Ribakovsky, MD, Meirav Kedmi, MD, Adrian Duek, MD, Drorit Merkel, MD, Merav Leiba, MD, Ivetta Danylesko, MD, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Avichai Shimoni, MD, Abraham Avigdor, MD, Arnon Nagler, Yulia Volchek, MD
Journal: Blood
Blood (2016) 128 (22): 5429.
https://doi.org/10.1182/blood.V128.22.5429.5429
Published: 2016
Journal Articles

Prognostic Value of Interim and End of Treatment FDG-PET/CT Scan Results in Adult Patients with Burkitt Lymphoma - a Retrospective Analysis of a Single Center Cohort

Eldar Priel, MD, Meirav Kedmi, MD, Tima Davidson, MD, Ginette Schiby, MD, Elena Ribakovsky, MD, Ohad Benjamini, MD, Arnon Nagler, MD MSc, Abraham Avigdor, MD
Journal: Blood
Blood (2015) 126 (23): 5025.
https://doi.org/10.1182/blood.V126.23.5025.5025
Published: 2015
Journal Articles

High Risk Adva­nced Stage Hodgkin Lymphoma Is Well Controlled with 2 Cycles of Escalated Beacopp Followed By 4 Cycles of ABVD in Patients Who Rapidly Achieve Metabolic CR on Interim PET/CT Scan

Meirav Kedmi, MD, Arie Apel, MD, Tima Davidson, MD, Elinor Goshen, MD, Yaron Davidovitz, MD, Miriam Berkowicz, MD, Itai Levi, MD, Eldad J. Dann, MD, Aaron Polliack, MD, Arnon Nagler, MD, Abraham Avigdor, MD
Journal: Blood
Blood (2014) 124 (21): 4442.
https://doi.org/10.1182/blood.V124.21.4442.4442
Published: 2014
Journal Articles

Low Proliferation Index May Be Associated with Longer Time to First Therapy In Low Grade Follicular Lymphoma

Meirav Kedmi, MD, Cyrus V. Hedvat, MD, PhD, Jocelyn Maragulia, Andrew D Zelenetz, MD
Journal: Blood
Blood (2010) 116 (21): 4149.
https://doi.org/10.1182/blood.V116.21.4149.4149
Published: 2010
Journal Articles

MDR1 Polymorphisms but Not GST Null Phenotypes Alter Susceptibility to Acute Myeloid Leukemia in Young Adult Israeli Patients.

Nava Asher, BSc Med, Sara Bar Cohen, PhD, Meirav Kedmi, MD, Maya Heled, Angela Risch, PhD, Deborah Rund, MD
Journal: Blood
Blood (2005) 106 (11): 2756.
https://doi.org/10.1182/blood.V106.11.2756.2756
Published: 2005
Journal Articles

Drug Metabolism and Disposition Genes in Israeli HIV Patients: MDR1 and CYP3A4 Polymorphisms May Affect Susceptibility to HIV but Not the Course of the Disease.

Meirav Kedmi, MD, Sara Bar Cohen, PhD, Michelle Hauzi, RN, Shlomo Maayan, MD, Deborah Rund, MD
Journal: Blood
Blood (2005) 106 (11): 1434.
https://doi.org/10.1182/blood.V106.11.1434.1434
Published: 2005
Journal Articles

Polymorphisms in Drug Metabolism/Disposition Genes and Increased Susceptibility to Adult De Novo AML: MDR1 and CYP3A4.

Meirav Kedmi, MD, Sara B. Cohen, PhD, Deborah Rund, MD
Journal: Blood
Blood (2004) 104 (11): 2078.
https://doi.org/10.1182/blood.V104.11.2078.2078
Published: 2004